Epm Therapeutics
epm Therapeutics is a biotechnology company focused on developing synthetic cannabinoid acid(CBDA) derivatives to address unmet medical needs in both rare and complex conditions. Our lead compound in development, EPM301, is exploring the potential of CBDA to improve symptoms of Prader-Willi Syndrome (PWS), including sleep/wake patterns, behavior, and hyperphagia (uncontrolled appetite). Our mission is rooted in scientific integrity and the hope that investigation can inspire. By advancing this promising science, we are focused to one day bring meaningful improvement in quality of life to both PWS patients and their caregivers.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Epm Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Epm Therapeutics
1 distinct titles indexed · top 1 shown.
- 1president and coo
Sign up to unlock all 1 contacts at Epm Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Epm Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.